D. M. Parkin

Oncology · 2001–2021

A researcher in the Science corpus: 11 papers; trusts 4 researchers and is trusted by 17 researchers here, as inferred from the citation graph.

Subfields

• Oncology — 22 citations into it; #86 of 1,698 by trust here, #111 by citations
• Epidemiology — 19 citations into it; #1,494 of 2,148 by trust here, #135 by citations

Whom D. M. Parkin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Ferlay
2. X. Castellsagué
3. John D. Potter
4. R. Biggar
5. F. Bray

Who trusts D. M. Parkin overall

1. R. Siegel
2. F. Bray
3. A. Jemal
4. J. Ferlay
5. Marcy J. Balunas
6. Lindsey A. Torre
7. D. Parkin
8. X. Zhang
9. Yezaz A. Ghouri
10. H. B. EL‐SERAG

Papers from D. M. Parkin's perspective

Ordered by how strongly the researchers D. M. Parkin trusts endorse each paper. Same corpus, a different order for every researcher.

1. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. (Journal of the National Cancer Institute)
2. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. (New England Journal of Medicine)
3. Counting the dead and what they died from: an assessment of the global status of cause of death data. (Bulletin of the World Health Organization)
4. Overview of the main outcomes in breast-cancer prevention trials. (The Lancet)
5. Against which human papillomavirus types shall we vaccinate and screen? the international perspective (International Journal of Cancer)
6. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. (Journal of the National Cancer Institute)
7. Overweight as an avoidable cause of cancer in Europe (International Journal of Cancer)
8. Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease (British Journal of Cancer)
9. Breast cancer and hormone-replacement therapy: the Million Women Study. (The Lancet)
10. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. (The Lancet)

Their papers

• Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population (2002) — 760 citations
• Cancer statistics for the year 2020: An overview (2021) — 4,841 citations
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 (2015) — 27,202 citations
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] (2013) — 2,860 citations
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 (2010) — 21,956 citations
• Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. (2009) — 845 citations
• The global health burden of infection‐associated cancers in the year 2002 (2006) — 3,046 citations
• The changing global patterns of female breast cancer incidence and mortality (2004) — 1,032 citations
• Estimating the world cancer burden: Globocan 2000 (2001) — 3,992 citations
• Global cancer statistics in the year 2000. (2001) — 3,792 citations
• Globocan 2000 : cancer incidence, mortality and prevalence worldwide (2001) — 3,267 citations